GADDI, ANTONIO VITTORINO
 Distribuzione geografica
Continente #
EU - Europa 6.873
NA - Nord America 4.326
AS - Asia 1.075
AF - Africa 211
SA - Sud America 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.512
Nazione #
US - Stati Uniti d'America 4.316
IT - Italia 2.842
GB - Regno Unito 1.367
DE - Germania 649
SE - Svezia 502
UA - Ucraina 501
CN - Cina 444
VN - Vietnam 308
FR - Francia 262
IN - India 242
IE - Irlanda 185
RU - Federazione Russa 166
ZA - Sudafrica 98
EE - Estonia 85
BE - Belgio 63
CH - Svizzera 55
SC - Seychelles 43
TG - Togo 34
CI - Costa d'Avorio 33
NL - Olanda 33
PL - Polonia 33
BG - Bulgaria 28
JP - Giappone 27
GR - Grecia 21
RO - Romania 19
FI - Finlandia 18
JO - Giordania 16
AT - Austria 9
ES - Italia 9
BR - Brasile 8
CA - Canada 8
AU - Australia 7
SG - Singapore 7
TR - Turchia 7
CZ - Repubblica Ceca 6
LB - Libano 6
EU - Europa 5
MC - Monaco 4
SI - Slovenia 4
IR - Iran 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
EG - Egitto 2
HK - Hong Kong 2
HR - Croazia 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
KH - Cambogia 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.512
Città #
Southend 1.199
Fairfield 498
Chandler 471
Jacksonville 351
Ashburn 294
Princeton 270
Wilmington 260
Seattle 236
Woodbridge 236
Milan 233
Dong Ket 195
Ann Arbor 189
Dublin 182
Houston 167
Rome 163
Cambridge 160
Padova 131
Westminster 117
Nanjing 109
Bologna 96
Berlin 87
Turin 82
Saint Petersburg 69
Medford 59
Bremen 58
Brussels 58
Naples 54
Mülheim 51
Mahé 41
Hebei 40
Shenyang 39
Florence 38
Nanchang 38
Jinan 36
Dearborn 35
Bern 34
Lomé 34
Verona 34
Abidjan 33
San Diego 29
Sofia 28
Mountain View 27
Tokyo 26
Bari 24
Changsha 24
San Venanzo 23
Warsaw 23
Palermo 22
Redwood City 22
Boardman 20
Catania 20
Dallas 18
Olalla 18
Pune 18
Helsinki 17
Norwalk 17
Tianjin 17
Amman 16
Beijing 16
Jiaxing 16
Kunming 16
Torino 15
Haikou 12
Kuban 12
Perugia 12
Cagliari 11
Brescia 10
Des Moines 10
Ningbo 10
Paris 10
Zhengzhou 10
Cesena 9
Monza 9
Pescara 9
Taizhou 9
Vicenza 9
Chicago 8
Frankfurt am Main 8
Genoa 8
Modena 8
Napoli 8
Andover 7
Buffalo 7
Como 7
Falls Church 7
Genova 7
Hangzhou 7
Hefei 7
Los Angeles 7
San Francisco 7
Bergamo 6
Bucharest 6
Corciano 6
Forlì 6
Grafing 6
Lausanne 6
New York 6
Rimini 6
Trento 6
Venice 6
Totale 7.254
Nome #
La fame d’amore: un bambino che sta bene non piange. 2.072
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 816
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 171
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 140
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population. 135
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 128
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 127
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 126
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 124
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 124
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 123
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 122
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 119
Linkage disequilibrium patterns and tagSNP transferability among European populations. 118
Metabolic Syndrome prevalence in Italy. 118
Epidemiologia delle malattie cerebrovascolari. 116
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 114
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 112
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 112
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 111
Sources of variabilità of plasma HDL-cholesterol levels. 111
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 110
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 110
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 109
BlueC@rdio 102
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept. 101
Physical activity, exercise and cardiovascular health 100
null 98
The influence of statin medications on Prostate Specific Antigen levels. 98
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 98
null 98
Proteine della Soia. Effetti metabolici e ruolo nella prevenzione cardiovascolare 95
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 95
Attività fisica e aterosclerosi: i dati di Brisghella 94
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 94
null 93
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 91
Complementary and alternative medicine for hypertension. What evidence is there for herbalist suggestions? 91
Metabolic Effects of Pioglitazone and Rosiglitazone in patients with diabetes and metabolic syndrome treated with Glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. 91
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 91
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 90
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 88
Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. 88
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al. 88
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 88
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 88
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. 87
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster? 86
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 86
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 85
Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. 85
Modification of the dietary habits in the Brisighella Heart Study 85
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 83
null 83
Physical activity and cardiovascular disease mortality: the Brisighella heart study 82
null 82
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. 82
Brisghella Heart Study (BHS): ipertensione ed obesità. 82
Effect of Sulodexide on Albuminuria, NAG Excretion and Glomerular Filtration Response to Dopamine in Diabetic Patients. 82
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 79
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults? 79
Massa Lombarda Project (Prevention and control of cardiovascular diseases: Instant Individual Definition and Bluc@ardio Project) 79
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 79
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 79
Otoscopic examination: a diagnostic contribution for atherosclerotic disease? 79
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. 79
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. 77
Otoscopic findings in hypercholesterolemic subjects 77
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. 77
Piano Regionale della Prevenzione (2005-2008; volume 44) 76
null 74
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 74
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients. 74
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. 71
What herbalists suggest to our diabetic patients in order to improve their glycaemic control? Evaluation of scientific evidences and potential risks. 71
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 70
Non-pharmacological control of plasma cholesterol levels. 70
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 69
null 68
Practical reccomendations for Familial Combined Hyperlipidemia diagnosis and management: an update. 68
EUROLIVE 67
The relevance of soluble fibre dietary supplement in cardiovacular disease risk menagement of patients affected by metabolic syndrome (MS): a 1-year, open label, randomized clinical trial. 67
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 67
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 67
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?] 66
null 66
Metabolic syndrome and prevalence of instrumental atherosclerosis or its clinical complications in 1000 subjects affected by different forms of familial hyperlipoproteinemia. 66
Role of olive oil in the health: results form the Eurolive Study. 66
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 65
Software per l'identificazione automatica delle iperlipoproteinemie genetiche 64
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. 63
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. 63
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 62
eHealth: uno strumento di prevenzione cardiovascolare 61
Sito del core curriculum nazionale dei corsi di Laurea in Medicina e Chirurgia 61
Obesity related health risk and social cost. 59
Incontro sull'eccellenza didattica tra Dodenti della Facoltà di Medicina del Karolinska Institute e dell'Università di Bologna 59
null 57
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 56
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 56
Totale 11.545
Categoria #
all - tutte 24.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019484 0 0 0 0 0 0 0 0 116 171 63 134
2019/20202.805 523 84 80 204 228 274 311 383 293 196 76 153
2020/20212.092 374 147 78 132 69 154 82 141 175 148 157 435
2021/20222.152 198 88 134 134 210 145 50 152 87 119 456 379
2022/20232.759 302 317 148 346 148 168 130 191 388 147 301 173
2023/20241.529 97 212 126 157 168 230 194 168 177 0 0 0
Totale 12.732